ALERT:

Clinical Trial

Multiple Sclerosis, Obstructive Sleep Apnea Clinical Trial 20193115

[LCID Study Number: 20193115]

Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis

This is an observational study designed to measure the prevalence of sleep disordered breathing in multiple sclerosis. This study will also examine the relationship between fatigue and other sleep related issues, MS, and sleep disordered breathing.

Disease/Condition: Multiple Sclerosis, Obstructive Sleep Apnea

Department: Neurology

Location(s): Lahey Hospital & Medical Center (Burlington); Lahey Outpatient Center, Lexington

Primary Contact Email: Catia.S.Melo@lahey.org

Primary Contact Phone: 781-372-7194

Clinical Trial Details

Protocol #: 20193115

Principal Investigator(s): Pooja S. Raibagkar

Study Coordinator(s): Catia Melo

Trial Phase: Sponsor Initiated Study Observational